The global Gene Expression System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Gene Expression System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Gene Expression System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Gene Expression System in Biopharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Gene Expression System include RayBiotech, Lonza, Creative Biogene, Agilent Technologies, GenScript, OriGene, Eurofins Genomics, Bio Basic and GeneArt (Thermofischer), etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Expression System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Expression System.
The Gene Expression System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gene Expression System market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Expression System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
RayBiotech
Lonza
Creative Biogene
Agilent Technologies
GenScript
OriGene
Eurofins Genomics
Bio Basic
GeneArt (Thermofischer)
Segment by Type
Bacterial Gene Expression
Baculovirus Insect Cell Expression
Mammalian Gene Expression
Segment by Application
Biopharmaceutical Company
Research Institutions
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Expression System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Expression System Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Bacterial Gene Expression
1.2.3 Baculovirus Insect Cell Expression
1.2.4 Mammalian Gene Expression
1.3 Market by Application
1.3.1 Global Gene Expression System Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biopharmaceutical Company
1.3.3 Research Institutions
1.3.4 Hospital
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Expression System Market Perspective (2018-2029)
2.2 Gene Expression System Growth Trends by Region
2.2.1 Global Gene Expression System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Expression System Historic Market Size by Region (2018-2023)
2.2.3 Gene Expression System Forecasted Market Size by Region (2024-2029)
2.3 Gene Expression System Market Dynamics
2.3.1 Gene Expression System Industry Trends
2.3.2 Gene Expression System Market Drivers
2.3.3 Gene Expression System Market Challenges
2.3.4 Gene Expression System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Expression System Players by Revenue
3.1.1 Global Top Gene Expression System Players by Revenue (2018-2023)
3.1.2 Global Gene Expression System Revenue Market Share by Players (2018-2023)
3.2 Global Gene Expression System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Expression System Revenue
3.4 Global Gene Expression System Market Concentration Ratio
3.4.1 Global Gene Expression System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Expression System Revenue in 2022
3.5 Gene Expression System Key Players Head office and Area Served
3.6 Key Players Gene Expression System Product Solution and Service
3.7 Date of Enter into Gene Expression System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Expression System Breakdown Data by Type
4.1 Global Gene Expression System Historic Market Size by Type (2018-2023)
4.2 Global Gene Expression System Forecasted Market Size by Type (2024-2029)
5 Gene Expression System Breakdown Data by Application
5.1 Global Gene Expression System Historic Market Size by Application (2018-2023)
5.2 Global Gene Expression System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Expression System Market Size (2018-2029)
6.2 North America Gene Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Expression System Market Size by Country (2018-2023)
6.4 North America Gene Expression System Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Expression System Market Size (2018-2029)
7.2 Europe Gene Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Expression System Market Size by Country (2018-2023)
7.4 Europe Gene Expression System Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Expression System Market Size (2018-2029)
8.2 Asia-Pacific Gene Expression System Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Expression System Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Expression System Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Expression System Market Size (2018-2029)
9.2 Latin America Gene Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Expression System Market Size by Country (2018-2023)
9.4 Latin America Gene Expression System Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Expression System Market Size (2018-2029)
10.2 Middle East & Africa Gene Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Expression System Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Expression System Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 RayBiotech
11.1.1 RayBiotech Company Detail
11.1.2 RayBiotech Business Overview
11.1.3 RayBiotech Gene Expression System Introduction
11.1.4 RayBiotech Revenue in Gene Expression System Business (2018-2023)
11.1.5 RayBiotech Recent Development
11.2 Lonza
11.2.1 Lonza Company Detail
11.2.2 Lonza Business Overview
11.2.3 Lonza Gene Expression System Introduction
11.2.4 Lonza Revenue in Gene Expression System Business (2018-2023)
11.2.5 Lonza Recent Development
11.3 Creative Biogene
11.3.1 Creative Biogene Company Detail
11.3.2 Creative Biogene Business Overview
11.3.3 Creative Biogene Gene Expression System Introduction
11.3.4 Creative Biogene Revenue in Gene Expression System Business (2018-2023)
11.3.5 Creative Biogene Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Gene Expression System Introduction
11.4.4 Agilent Technologies Revenue in Gene Expression System Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 GenScript
11.5.1 GenScript Company Detail
11.5.2 GenScript Business Overview
11.5.3 GenScript Gene Expression System Introduction
11.5.4 GenScript Revenue in Gene Expression System Business (2018-2023)
11.5.5 GenScript Recent Development
11.6 OriGene
11.6.1 OriGene Company Detail
11.6.2 OriGene Business Overview
11.6.3 OriGene Gene Expression System Introduction
11.6.4 OriGene Revenue in Gene Expression System Business (2018-2023)
11.6.5 OriGene Recent Development
11.7 Eurofins Genomics
11.7.1 Eurofins Genomics Company Detail
11.7.2 Eurofins Genomics Business Overview
11.7.3 Eurofins Genomics Gene Expression System Introduction
11.7.4 Eurofins Genomics Revenue in Gene Expression System Business (2018-2023)
11.7.5 Eurofins Genomics Recent Development
11.8 Bio Basic
11.8.1 Bio Basic Company Detail
11.8.2 Bio Basic Business Overview
11.8.3 Bio Basic Gene Expression System Introduction
11.8.4 Bio Basic Revenue in Gene Expression System Business (2018-2023)
11.8.5 Bio Basic Recent Development
11.9 GeneArt (Thermofischer)
11.9.1 GeneArt (Thermofischer) Company Detail
11.9.2 GeneArt (Thermofischer) Business Overview
11.9.3 GeneArt (Thermofischer) Gene Expression System Introduction
11.9.4 GeneArt (Thermofischer) Revenue in Gene Expression System Business (2018-2023)
11.9.5 GeneArt (Thermofischer) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
RayBiotech
Lonza
Creative Biogene
Agilent Technologies
GenScript
OriGene
Eurofins Genomics
Bio Basic
GeneArt (Thermofischer)
*If Applicable.